Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Balaxi Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, Balaxi Pharmaceuticals had annual revenue of 2.70B INR, down -7.65%. Balaxi Pharmaceuticals had revenue of 707.14M in the quarter ending March 31, 2026, a decrease of -7.28%.

• Revenue: 2.70B
• Revenue Growth: -7.65%
• P/S Ratio: 0.47
• Revenue / Employee: 4.50M
• Employees: 600
• Market Cap: 1.26B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	2.70B	-223.88M	-7.65%
Mar 31, 2025	2.93B	512.67M	21.25%
Mar 31, 2024	2.41B	-951.38M	-28.28%
Mar 31, 2023	3.36B	570.45M	20.42%
Mar 31, 2022	2.79B	480.55M	20.77%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 14, 2026

Data Sources Report a data error